ClinicalTrials.Veeva

Menu

Respiratory Exacerbation Plans for Action and Care Transitions for Children With Severe CP (RE-PACT)

University of Wisconsin (UW) logo

University of Wisconsin (UW)

Status

Completed

Conditions

Cerebral Palsy

Treatments

Behavioral: RE-PACT Intervention

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05292365
R34HL153570-01A1 (U.S. NIH Grant/Contract)
A536771 (Other Identifier)
Protocol Version 2/24/2023 (Other Identifier)
2021-1532

Details and patient eligibility

About

This study will pilot test a just-in-time (JIT) adaptive intervention to reduce severe respiratory illness, for children with severe cerebral palsy (CP). The intervention program, called RE-PACT, delivers timely, customized action planning and health coaching when mobile text messaging with families predicts hospitalization risk is elevated. A total of n=90 caregivers of children with severe CP will be enrolled from the University of Wisconsin-Madison (UW) and the University of California, Los Angeles (UCLA) and can expect to be on study for up to 6 months.

Full description

The two-site study takes place at clinical programs at US children's hospitals: the UW and UCLA Pediatric Complex Care Pro-grams were each established to deliver care to children with medical complexity. Each program is comprised of primary care providers, care coordinators, and extended visit lengths, deliver comprehensive care to children with cerebral palsy. These sites have existing collaborative relationships through their participation in the CYSHCNet national research network (http://cyshcnet.org) and other federally funded initiatives, and a track record of successful productive scientific collaboration.

The study period will be divided into three waves: after each wave, feasibility, acceptability, and fidelity data will be reviewed against pre-defined measures of success to adjust the protocol and overcome implementation barriers.

This study will be conducted through a six-month randomized pilot trial. Briefly, after recruitment and baseline assessments, eligible caregiver/child dyads are randomized to intervention (I) or active control (AC). Intervention subjects receive respiratory illness action plans and weekly mobile health (mHealth) confidence surveillance. At times of low confidence or hospitalization, just-in-time action planning and coaching activities are conducted. AC subjects will receive usual comprehensive medical care and coordination. Assessments of feasibility, acceptability and fidelity, as well as clinical outcomes, will be conducted at baseline and monthly intervals for 6 months. Intervention outcomes will be evaluated at baseline (i.e., randomization) and 6 months post-enrollment, and will also include the primary clinical outcome (i.e., hospitalization for respiratory diagnosis).

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Be at least 18 years of age

  • Primary caregiver to an eligible child (child criteria below)

  • Speak English or Spanish well enough to be interviewed

  • Have a phone capable of sending/receiving text messages

  • Has a child

    • age 0-17 years
    • with Gross Motor Function Classification System level IV or V Cerebral Palsy
    • Cared for by respiratory specialist or receive daily respiratory treatments (oxygen, ventilation, airway clearance device, medications)

Exclusion criteria

  • Lack of interest in text messaging or coaching interactions during the study

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

RE-PACT Intervention
Experimental group
Description:
Intervention participants receive respiratory illness action plans and weekly mobile health (mHealth) confidence surveillance. At times of low confidence or hospitalization, just-in-time action planning and coaching activities are conducted.
Treatment:
Behavioral: RE-PACT Intervention
Active Control (AC)
No Intervention group
Description:
AC subjects will receive usual comprehensive medical care and coordination.

Trial documents
2

Trial contacts and locations

2

Loading...

Central trial contact

Gemma Warner, CCRC, MSSW

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems